selexipag
PolandDrugs containing this active substance
-
The medicine is used for the long-term treatment of pulmonary arterial hypertension (PAH) in adults. It helps to dilate the pulmonary arteries, which makes it easier for the heart to pump blood, lowers the pressure in these arteries, and relieves the symptoms of the disease.
Form: tablets, film-coated
Active substance Dosage selexipag 200 mcg ATC: B01AC27
Manufacturer: Synthon B.V. Synthon Hispania S.L. Synfon s.r.o.
-
This medicine is used for the long-term treatment of pulmonary arterial hypertension (PAH) in adults. It helps to dilate the pulmonary arteries, which lowers the pressure within them, relieves disease symptoms, and slows its progression.
Form: tablets, film-coated
Active substance Dosage selexipag 400 mcg ATC: B01AC27
Manufacturer: Synthon B.V. Synthon Hispania S.L. Synfon s.r.o.
-
The medicine is used for the long-term treatment of pulmonary arterial hypertension (PAH) in adults. It helps to dilate the pulmonary arteries, which makes it easier for the heart to pump blood, lowers the pressure in these arteries, relieves disease symptoms, and slows its progression.
Form: tablets, film-coated
Active substance Dosage selexipag 600 mcg ATC: B01AC27
Manufacturer: Synthon B.V. Synthon Hispania S.L. Synfon s.r.o.
-
The medicine is used for the long-term treatment of pulmonary arterial hypertension (PAH) in adults. It helps to dilate the pulmonary arteries, which lowers the pressure within them, relieves disease symptoms, and slows its progression.
Form: tablets, film-coated
Active substance Dosage selexipag 800 mcg ATC: B01AC27
Manufacturer: Synthon B.V. Synthon Hispania S.L. Synfon s.r.o.
-
The medicine is used for the long-term treatment of pulmonary arterial hypertension (PAH) in adults. It helps to dilate the pulmonary arteries, which makes it easier for the heart to pump blood, lowers the pressure in these arteries, relieves disease symptoms, and slows its progression.
Form: tablets, film-coated
Active substance Dosage selexipag 1000 mcg ATC: B01AC27
Manufacturer: Synthon B.V. Synthon Hispania S.L. Synfon s.r.o.
-
This medicine is used for the long-term treatment of pulmonary arterial hypertension (PAH) in adults. It helps to dilate the pulmonary arteries, which makes it easier for the heart to pump blood, lowers the pressure in these arteries, and may slow the progression of the disease.
Form: tablets, film-coated
Active substance Dosage selexipag 1200 mcg ATC: B01AC27
Manufacturer: Synthon B.V. Synthon Hispania S.L. Synfon s.r.o.
-
The medicine is used for the long-term treatment of pulmonary arterial hypertension (PAH) in adults. It helps to dilate the pulmonary arteries, which makes it easier for the heart to pump blood, lowers the pressure in these arteries, and relieves the symptoms of the disease.
Form: tablets, film-coated
Active substance Dosage selexipag 1400 mcg ATC: B01AC27
Manufacturer: Synthon B.V. Synthon Hispania S.L. Synfon s.r.o.
-
The medicine is used for the long-term treatment of pulmonary arterial hypertension (PAH) in adults. It helps to dilate the pulmonary arteries, which makes it easier for the heart to pump blood, lowers the pressure in these arteries, and relieves the symptoms of the disease.
Form: tablets, film-coated
Active substance Dosage selexipag 1600 mcg ATC: B01AC27
Manufacturer: Synthon B.V. Synthon Hispania S.L. Synfon s.r.o.
-
The medicine is used for the long-term treatment of pulmonary arterial hypertension (PAH) in adult patients for whom other medicines have not produced the expected effects or who cannot use them.
Form: tablets, film-coated
Active substance Dosage selexipag 200 mcg ATC: B01AC27
Manufacturer: Synthon B.V. Synthon Hispania S.L. Synfon s.r.o.
-
The medicine is used for the long-term treatment of pulmonary arterial hypertension (PAH) in adults. It may be used alone or in combination with other medicines if the patient cannot take them.
Form: tablets, film-coated
Active substance Dosage selexipag 400 mcg ATC: B01AC27
Manufacturer: Synthon B.V. Synthon Hispania S.L. Synfon s.r.o.
-
This medicine is used for the long-term treatment of pulmonary arterial hypertension (PAH) in adult patients. It may be used alone or in combination with other medicines if the patient is not eligible for their use.
Form: tablets, film-coated
Active substance Dosage selexipag 600 mcg ATC: B01AC27
Manufacturer: Synthon B.V. Synthon Hispania S.L. Synfon s.r.o.
-
This medicine is used for the long-term treatment of pulmonary arterial hypertension (PAH) in adults. It helps to dilate the pulmonary arteries, which makes it easier for the heart to pump blood, lowers the pressure in these arteries, relieves disease symptoms, and slows its progression.
Form: tablets, film-coated
Active substance Dosage selexipag 800 mcg ATC: B01AC27
Manufacturer: Synthon B.V. Synthon Hispania S.L. Synfon s.r.o.
-
The medicine is used for the long-term treatment of pulmonary arterial hypertension (PAH) in adult patients for whom other medicines have not produced the expected effects or when other treatment methods cannot be used.
Form: tablets, film-coated
Active substance Dosage selexipag 1000 mcg ATC: B01AC27
Manufacturer: Synthon B.V. Synthon Hispania S.L. Synfon s.r.o.
-
The medicine is used for the long-term treatment of pulmonary arterial hypertension (PAH) in adults. It may be used alone or in combination with other medicines if the patient is not eligible for their use.
Form: tablets, film-coated
Active substance Dosage selexipag 1200 mcg ATC: B01AC27
Manufacturer: Synthon B.V. Synthon Hispania S.L. Synfon s.r.o.
-
The medicine is used for the long-term treatment of pulmonary arterial hypertension (PAH) in adult patients. It may be used alone or in combination with other medicines if previous treatments have not been effective.
Form: tablets, film-coated
Active substance Dosage selexipag 1400 mcg ATC: B01AC27
Manufacturer: Synthon B.V. Synthon Hispania S.L. Synfon s.r.o.
-
This medicine is used for the long-term treatment of pulmonary arterial hypertension (PAH) in adults. It may be used alone or in combination with other medicines.
Form: tablets, film-coated
Active substance Dosage selexipag 1600 mcg ATC: B01AC27
Manufacturer: Synthon B.V. Synthon Hispania S.L. Synfon s.r.o.